Manufacturer record
Brilliant Lifesciences Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Brilliant Lifesciences Pvt Ltd (Gujarat) were declared Not of Standard Quality between April 2022 and April 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 1125, Amlodipine Besylate Tablets IP 5 mg (exp Oct 2026). CDTL Indore (CDSCO lab) found it not of standard quality: Dissolution. Listed in the April 2024 alert.
Records by type
2 records linked to Brilliant Lifesciences Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amlodipine Besylate Tablets IP 5 mg | Batch 1125Mfg Nov 2023 · Exp Oct 2026 | DissolutionDissolution | CDTL IndoreCDSCO lab | Apr 2024 |
| Sodium Valproate Tablets I.P. 200 mg | Batch BT5871Mfg Aug 2021 · Exp Jul 2023 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Apr 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.